Drug Shortage Report for LOTEMAX
Report ID | 67787 |
Drug Identification Number | 02321114 |
Brand name | LOTEMAX |
Common or Proper name | LOTEMAX |
Company Name | BAUSCH & LOMB INC |
Market Status | MARKETED |
Active Ingredient(s) | LOTEPREDNOL ETABONATE |
Strength(s) | 0.5% |
Dosage form(s) | SUSPENSION |
Route of administration | OPHTHALMIC |
Packaging size | 10ml |
ATC code | S01BA |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-01-09 |
Estimated end date | Unknown |
Actual end date | 2019-02-05 |
Shortage status | Resolved |
Updated date | 2019-02-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1400 N GOODMAN STREET ROCHESTER, NEW YORK UNITED STATES 14609 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2019-02-06 | English | Compare |
v9 | 2019-01-23 | French | Compare |
v8 | 2019-01-23 | English | Compare |
v7 | 2019-01-10 | French | Compare |
v6 | 2019-01-10 | English | Compare |
v5 | 2018-12-17 | French | Compare |
v4 | 2018-12-17 | English | Compare |
v3 | 2018-12-16 | English | Compare |
v2 | 2018-11-28 | French | Compare |
v1 | 2018-11-28 | English | Compare |
Showing 1 to 10 of 10